Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid

Baronio, Diego and Castro, Kamila and Gonchoroski, Taylor and de Melo, Gabriela Mueller and Nunes, Gustavo Della Flora and Bambini-Junior, Victorio and Gottfried, Carmem and Riesgo, Rudimar (2015) Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid. PLoS ONE, 10 (1). ISSN 1932-6203

Full text not available from this repository.

Abstract

Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders primarily characterized by impaired social interaction and communication, and by restricted repetitive behaviors and interests. Ligands of histamine receptor 3 (H3R) are considered potential therapeutic agents for the treatment of different brain disorders and cognitive impairments. Considering this, the aim of the present study is to evaluate the actions of ciproxifan (CPX), an H3R antagonist, on the animal model of autism induced by prenatal exposure to valproic acid (VPA). Swiss mice were prenatally exposed to VPA on embryonic day 11 and assessed for social behavior, nociceptive threshold and repetitive behavior at 50 days of life. The treatment with CPX (3 mg/kg) or saline was administered 30 minutes before each behavioral test. The VPA group presented lower sociability index compared to VPA animals that were treated with CPX. Compared to the Control group, VPA animals presented a significantly higher nociceptive threshold, and treatment with CPX was not able to modify this parameter. In the marble burying test, the number of marbles buried by VPA animals was consistent with markedly repetitive behavior. VPA animals that received CPX buried a reduced amount of marbles. In summary, we report that an acute dose of CPX is able to attenuate sociability deficits and stereotypies present in the VPA model of autism. Our findings have the potential to help the investigations of both the molecular underpinnings of ASD and of possible treatments to ameliorate the ASD symptomatology, although more research is still necessary to corroborate and expand this initial data.

Item Type:
Journal Article
Journal or Publication Title:
PLoS ONE
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700
Subjects:
ID Code:
168524
Deposited By:
Deposited On:
12 Apr 2022 15:00
Refereed?:
Yes
Published?:
Published
Last Modified:
03 May 2022 04:27